Single names, sectors, valuations and the trades behind the tape, explained in plain language.

Zymeworks will acquire Theravance Biopharma for $17 per share in a $929 million all-cash deal. The transaction includes a 10-year contingent

CVC Capital Partners has agreed to buy IRCA, an Italian supplier of dessert ingredients, from rival private equity firm Advent International

Bridgepoint, a UK private equity firm, agreed to buy Kayne Anderson's US real estate business for $1.4 billion. The deal adds $22 billion in

British American Tobacco is overhauling 9,000 roles through an AI-driven restructuring, targeting £600 million in annual savings by 2028. US

Samsung Biologics shares jumped nearly 8% after its union voted to leave the Samsung Group federation. The move eased fears of coordinated l

Haleon, the British consumer healthcare giant, has joined the race to acquire Thorne, a fast-growing supplements brand owned by L Catterton.

Berenberg argues CTP's recent share slump unfairly lumps it with rate-sensitive European real estate, ignoring its large landbank and logist

Berenberg raised its medium-term earnings growth outlook for Allianz after the insurer's Inside Allianz Series in Munich. The investment ban

Berenberg upgraded Bellway to buy, highlighting a 4% dividend and £150 million annual buyback. The bank argues generous cash returns could m

Persistent Systems shares sank as much as 10.6% after the Indian IT firm offered €1 billion for Germany's Nagarro at a 100% premium. Analyst

Fitch Ratings affirmed Larsen & Toubro's BBB+ rating with a stable outlook, citing strong margins and a deep order book. The agency noted L&

Fitch reaffirmed China Galaxy Securities' BBB+ rating on June 26, pointing to potential support from state-owned Central Huijin. The broker'